Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Sale and Maturity of Investments (2014)

Updated

Elite Pharmaceuticals (ELTP) reported Sale and Maturity of Investments - Total of $5 million for FY2015 (year ended Mar 31, 2015).

Analysis

Elite Pharmaceuticals (ELTP) Sale and Maturity of Investments (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 308.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - 88.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 2.53 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 5.00 Mn
API Access

Elite Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ELTP&period=max&api_key=YOUR_API_KEY